Evidence map›Paper›PMID 42170027›Full record

ArticleBioinformatics advances2026

MPore: database-driven identification of active methyltransferases in prokaryotic genomes from nanopore sequencing.

Azlan Nisar, Lars Vogelgsang, Sebastian Fuchs, Klaus Pfeffer, Birgit Henrich, Alexander Dilthey

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Azlan NisarInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.ORCID https://orcid.org/0009-0009-2898-608X
Lars VogelgsangInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.
Sebastian FuchsInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.
Klaus PfefferInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.
Birgit HenrichInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.
Alexander DiltheyInstitute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Universitäts str. 1, Düsseldorf, North-rhine-westphalia, 40225, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: In prokaryotic genomes, methylation is an important epigenetic modification that regulates the uptake of foreign DNA; it can also contribute to replication or virulence. We present MPore, a novel method for the database-driven detection of active methyltransferases and their associated target site recognition motifs from Nanopore R10 sequencing data of prokaryotic isolates. In contrast to existing methods, which typically start with the Results: On two benchmarking datasets, 10 bacterial monocultures and two Availability and implementation: MPore is freely available under the MIT license at https://github.com/DiltheyLab/MPore.

Identifiers

PMID42170027
PMCPMC13189711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.